Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCMA-CD3 Bispecific”

38 trials

Showing 20 of 38 results

Large-scale testing (Phase 3)Looking for participantsNCT05730036
What this trial is testing

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 410
Not applicableLooking for participantsNCT05106387
What this trial is testing

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Who this might be right for
Chronic Kidney Disease (CKD)
Regeneron Pharmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT05228470
What this trial is testing

Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Who this might be right for
ElranatamabMyelomaMultiple Myeloma+8 more
Pfizer 39
Early research (Phase 1)Not Yet RecruitingNCT07407010
What this trial is testing

BCMA/CD3 Bispecific Antibody as Bridging Therapy Before CAR-T Cell Infusion in RRMM

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)Looking for participantsNCT06900010
What this trial is testing

Evaluate CM336 in Adults with Autoimmune Bullous Disease

Who this might be right for
Autoimmune Bullous Disease
Shandong First Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT03761108
What this trial is testing

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals 387
Testing effectiveness (Phase 2)Active Not RecruitingNCT04557098
What this trial is testing

Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematological Malignancies
Janssen Research & Development, LLC 194
Large-scale testing (Phase 3)Looking for participantsNCT07222761
What this trial is testing

Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 915
Testing effectiveness (Phase 2)Study completedNCT07102706
What this trial is testing

Phase I Trial of GR1803 Injection in Patients With RRMM

Who this might be right for
Multiple Myeloma (MM)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT04696809
What this trial is testing

Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematologic Malignancies
Janssen Pharmaceutical K.K. 40
Testing effectiveness (Phase 2)Looking for participantsNCT05828511
What this trial is testing

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals 149
Testing effectiveness (Phase 2)Looking for participantsNCT06799611
What this trial is testing

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)Treatment
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Study completedNCT04798586
What this trial is testing

MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Pfizer 4
Testing effectiveness (Phase 2)Looking for participantsNCT07106684
What this trial is testing

ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Looking for participantsNCT05137054
What this trial is testing

Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals 317
Testing effectiveness (Phase 2)Active Not RecruitingNCT04649359
What this trial is testing

MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

Who this might be right for
Multiple Myeloma
Pfizer 187
Testing effectiveness (Phase 2)Looking for participantsNCT07151690
What this trial is testing

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Who this might be right for
Systemic Light Chain Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 21
Not applicableStudy completedNCT05565391
What this trial is testing

Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 508
Testing effectiveness (Phase 2)Looking for participantsNCT07348055
What this trial is testing

GR1803 in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErthematosusAuto Immune Disease
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 44
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation